newsfilter
← Latest News
GlobeNewswire·

IsoPlexis Reports Preliminary Full Year 2022 Revenue

BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced its preliminary